ChargePoint Technology and STERIS collaborate to offer fully validated sterile transfer solution


ChargePoint Technology, STERIS

July 13, 2020

Powder containment and sterile transfer solutions experts, ChargePoint Technology, today announced that it has entered into a collaboration with STERIS, a leading provider of infection prevention and other procedural products and services, to offer a unique and integrated solution for sterile product transfer.

Integrating ChargePoint’s AseptiSafe® Bio Transfer Valve with the STERIS VHP® Biodecontamination Systems, this offering provides users with a fully validated solution for the sterile transfer of drug substances and drug products during biopharmaceutical manufacturing.

As regulations around sterile/aseptic processing continue to expand, many manufacturers are looking for sterile transfer solutions that do not compromise operational efficiency. The ChargePoint split butterfly valve (SBV) technology enables contained transfers into a manufacturing process, providing sterility assurance during aseptic processing. The technology reduces the need for operator intervention and for cleaning and validating large areas, leading to minimal downtime and improving efficiencies during manufacturing.

Christian Dunne, head of sterile solutions at ChargePoint Technology, said: “This collaboration was a natural step for ChargePoint since we’ve been working with STERIS on different applications for nearly a decade. Combining expertise from the two teams ensures that we are able to offer customers across the globe a unique and efficient solution to one of today’s drug manufacturing challenges.”

Edward Markewitz, VHP Product Manager at STERIS, commented: “We are thrilled to be working with ChargePoint Technology and its unique aseptic SBV systems in conjunction with STERIS VHP. Collectively we are meeting the technical needs of the industry and using our expertise to provide the ultimate sterile transfer solution for products.”

The AseptiSafe® Bio Transfer Valve uses an enhanced decontamination step, exposing the SBV discs to vaporised hydrogen peroxide (VHP) gas within a sealed chamber. This provides a validated 6-log reduction in bioburden during the drug substance transfer process and removes the need for high grade clean room environments around the process.

The STERIS VHP® Generators provide an all-in-one system unit for biodecontamination in medical, biological and pharmaceutical facilities. The generators utilise STERIS Vaprox® Hydrogen Peroxide Sterilant (EPA Reg. No. 58779-4 and ECHA BPR Registered) as a means of achieving dry, low temperature biodecontamination within sealed enclosures for maximum biodecontamination.

For more information about ChargePoint Technology’s sterility assurance solutions, visit our dedicated section on the website here

Alternatively, STERIS and ChargePoint are co-presenting a webinar on July 28th, 10 – 11am EDT.

Entitled “Introducing a Fully Validated Sterile Product Transfer Solution for Biopharmaceutical Production” – presented by Bruno Aze – Global VHP Applications Technical Lead & Projects Manager at STERIS and Christian Dunne – Head of Sterile Solutions at ChargePoint Technology.

Registration for the webinar is:

For further information, images and interview opportunities with ChargePoint Technology, please contact Celine Goodier at ramarketing | | +44 (0)191 222 1242 | |

About ChargePoint Technology
ChargePoint Technology is the trusted specialist for safe and reliable contained and sterile transfer solutions in the pharmaceutical, biotech, chemical and other process industries. Its client portfolio includes some of the top 35 pharmaceutical companies and reaches into North America, UK, Europe, China and India, amongst others. ChargePoint Technology manufactures its cutting-edge devices in its purpose-built facility in Liverpool, UK, employs more than 90 employees across the globe and secured a multi-millionpound investment from LDC, part of Lloyds Banking Group in January 2017, to meet the increase in global demand for its products and solutions. For more information, please visit

The product range includes:
• Containment solutions – ChargePoint’s containment solutions provide a reduced risk of cross contamination via closed transfers, ensure the safety of your personnel and provide a dust free environment when processing toxic powders and high potent APIs.
• Sterility assurance solutions – ChargePoint’s product range for sterility assurance has been developed to perform aseptic transfers that maintain critical area integrity, reduce risk of
contamination via closed transfers and meet GMP and product quality requirements.
• Single use solutions – ChargePoint’s single use solutions provide the containment and sterility assurance required for handling high potent ingredients and chemicals with the cost effectiveness of disposable technology

About Steris
STERIS Life Sciences is your trusted partner in contamination control. For over 100 years, STERIS has been a global leader and expert in the industries of sterilization, cleaning and infection control. Today, we continue to build on this heritage by providing the products and resources you need throughout every step of your process. From innovation to results, our comprehensive portfolio of products and services is designed to meet your needs. With offices located worldwide and technicians in over 100 countries, you can count on us to be where you are when you need us, every step of the way. Trust STERIS Life Sciences to help you create a healthier and safer world.

STERIS VHP®, utilizing Vaprox® Sterilant, is an effective, low-temperature decontamination and sterilization technology that can be efficiently deployed within rooms and enclosures. The patented small molecule dry-process offers a broad range of efficacy and material compatibility that can be validated through the use of biological and chemical indicators. For more information, please visit

Post a Comment

You must be logged in to post a Comment.